CSTL

Castle Biosciences Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth↑ 7/10
  • Value↓ 2/10
Castle Biosciences sales and earnings growth
CSTL Growth
Good
  • Revenue Y/Y↓ 3.66%
  • EPS Y/Y↓ -225.76%
  • FCF Y/Y↓ -22.39%
Castle Biosciences gross and profit margin trends
CSTL Profitability
Neutral
  • Gross margin ↑ 79.40%
  • EPS margin↓ -7.00%
  • ROIC 5Y↓ -16.32%
Castle Biosciences net debt vs free cash flow
CSTL Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -342.2

Castle Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Diagnostics & Research stocks ↗